In this week’s set of Homerun Slides, we begin a four part series on how weight gain affects the overall health of our overweight and obese type 2 diabetes patients and the many ways the positive effects of weight loss can be maximized to improve health….
Read More »Monthly Archives: August 2012
Dr. Gregory Frost Introduction
Dr. Frost introduces himself to us and talks about Halozyme, and how the company tries to "think outside the cell," working to "smooth out" the blood sugar rollercoaster that diabetes patients too often find themselves on. More videos with Dr. Frost: Dr. Gregory Frost Q1 What Is Halozyme’s Current Focus? Dr. Gregory Frost …
Read More »Dr. Gregory Frost Q1 What Is Halozyme’s Current Focus?
Dr. Frost talks about the background and history of Halozyme’s product development and the critical need for more effective insulins. More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do? Dr. Gregory Frost Q3 Starting Baselines and …
Read More »Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do?
Dr. Frost goes over some of the details of the Halozyme study including how researchers looked at both type 1 and type 2 patients, the incidence of hypoglycemia, and the overall positive results. More videos with Dr. Frost: Dr. Gregory Frost Introduction Dr. Gregory Frost Q1 What Is Halozyme’s Current …
Read More »Dr. Gregory Frost Q3 Possible Breakthrough with an Insulin Additive
Dr. Frost talks about the results of the Halozyme study and the positive results, including a drop in A1c from the 8 range in type 2 diabetes patients to around 6.8. He also lets us know how the reduced use of better-designed insulins could even result in some weight loss, …
Read More »GLP-1 Agonist Effects on Glucagon Suppression
Alan Mathis, PharmD Candidate 2013, University of Florida College of Pharmacy The pathophysiology of type-2 diabetes is characterized by insulin resistance and beta-cell dysfunction. In addition, the presence of high levels of glucagon in the blood also seems to play an important role in the disease. Glucagon-like peptide-1 (GLP-1) is a …
Read More »Why the Physical Inactivity of Youth Is a Growing Problem
By Sheri Colberg, PhD How much exercise are kids actually getting nowadays? Not nearly enough!
Read More »Letter from the Editor, #640: Is There a New Cure for Type 1 with an Old Vaccine?
This week, there’s a lot in the press about the use of an old TB vaccine to "cure" type 1 diabetes. Our publisher, Steve Freed, has put together a fantastic synopsis that cuts through the hype and delivers the real story: check out Item #1, Faustman’s Type 1 Diabetes Cure …
Read More »Generic Actoplus Met® Tablets and Generic Actos® Tablets
Generic Actoplus Met® Tablets and Generic Actos® Tablets Mylan, Inc. announced that it has received final approval from FDA for its Abbreviated New Drug Application (ANDA) for Pioglitazone Tablets USP, 15 mg, 30 mg and 45 mg. Previously, the company also received final approval from the FDA for its ANDA …
Read More »Inactivity Is US Kids’ Biggest Health Problem
Lack of exercise tops the list of the biggest concerns about kids’ health, according to a new survey of American adults. The plight of young couch potatoes outranked teen pregnancy and drug abuse as problems that adults are concerned about, according to the survey. Not getting enough exercise was ranked …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.